Zumilokibart (APG777) trials continue to advance in atopic dermatitis (AD) with plans for expansion indications underway:- APEX Phase 2 Part A 52-week data expected this month- APEX Phase 2 Part B ...
According to the latest report by Mordor Intelligence, electric vehicles market size is entering a high-growth phase, rising from USD 0.67 trillion in 2025 to USD 0.75 trillion in 2026, and projected ...
This study presents valuable findings implicating nuclear export in the regulation of protein condensate behaviour and TDP-43 phase behaviour, suggesting a link to pathogenic aggregation in ALS/FTD.